The in vitro activity of sisomicin, netilmicin, nafcillin, and oxacillin against 35 strains of Staphylococcus aureus isolated from blood cultures ofpatients with endocarditis or septicemia was studied. The effects of combinations of either of the two newer aminoglycosides and either of the two penicillinase-resistant penicillins on the killing of S. aureus were investigated. All S. aureus strains were susceptible to the four antibiotics. Enhancement of antistaphylococcal activity was demonstrated by the antibiotic combinations.
It has been demonstrated that aminoglycosides in general enhance the antistaphylococcal activity of penicillinase-resistant penicillins (6) . Sisomicin and netilmicin are two new semisynthetic aminoglycosides closely related to gentamicin (2, 4, 5) . In this investigation, we studied the in vitro activity of sisomicin and netilmicin against Staphylococcus aureus and the effects of the combinations of either sisomicin or netilmicin with nafcillin or oxacillin on the killing of S. aureus.
MATERIALS AND METHODS S. aureus. Thirty-five strains of S. aureus isolated from blood cultures of 35 patients with endocarditis or septicemia were studied. was used. The inoculum was 0.002 ml of a 10-2 dilution of an overnight culture (approximately 103 to 104 organisms) delivered by a Steers replicator (3) .
Test of enhancement of activity. The time-kill curve method was used. An overnight culture of S.
aureus was diluted with Mueller-Hinton broth to netilmicin against S.
Comparisons of the effectiveness of antibiotic combinations with that of each antibiotic alone in the killing of 35 strains of S. aureus are presented in Table 2 . When the results from antibiotic combinations were compared with those from nafcillin or oxacillin alone, significantly enhanced killing was demonstrated against all strains at 6 h and against the majority of strains at 24 and 48 h. On the other hand, when comparisons were made of the results from antibiotic combinations and those from sisomicin or netilmicin alone, a significant decrease in viable CFU was demonstrated against only one to two strains at 6 h but against increasing numbers at 24 and 48 h. Figures 1 and 2 show typical results.
Another way of assessing the enhancement of activity is by comparing the viable CFU at 6, 24, and 48 h. Table 3 shows the number of strains with '100 viable CFU per ml in different antibiotic systems. With nafcillin and oxacillin alone; at no time was there decrease of viable CFU to c 100 per ml. With the combinations, especially nafcillin plus sisomicin and oxacillin plus sisomicin, significant numbers of strains showed .100 viable CFU per ml at 48 h.
The results of this study demonstrate that both sisomicin and netilmicin are active against S. aureus and that both of these new semisynthetic aminoglycosides enhance the killing of S. aureus by nafcillin and oxacillin.
